Heparin Sodium in 5% Dextrose Injection — Class II drug recall D-1425-2014
Terminated recall by Hospira Inc., reported 2014-07-16, distributed nationwide. Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
| Recall number | D-1425-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2014-06-06 |
| Classified | 2014-07-09 |
| Reported by FDA | 2014-07-16 |
| Terminated | 2015-04-03 |
| Distributed | Nationwide (US) |
| Quantity | 142,152 bags |
| Reason classes | sterility, packaging |
| NDC | 00409-4520, 00409-4520-02, 00409-4520-30, 00409-7793, 00409-7793-13, 00409-7793-23, 00409-7793-52, 00409-7793-62, 00409-7794, 00409-7794-52, 00409-7794-62 |
| Lot numbers | 1/16, 12/15, 2/16, 34-811-KL, 36-101-KL, 36-106-KL, 36-114-KL, 37-202-KL, 38-302-KL, 38-305-KL |
Product
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62
Reason for recall
Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1425-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.